1. Inhibition of Cell Growth, Induction of Apoptosis and Mechanism of Action of the Novel Platinum Compound cis-Diaminechloro-[2-(Diethylamino) Ethyl 4-Amino-Benzoate, N⁴]-Chloride Platinum (II) Monohydrochloride Monohydrate

   • Maria A. Mariggiò
   • Sergio Cafaggi
   • Maurizio Viale

   OriginalPaper Pages: 3 - 16

2. The Antiangiogenic Agent Neovastat (Æ-941) Stimulates Tissue Plasminogen Activator Activity

   • Denis Gingras
   • Dominique Labelle
   • Richard Béliveau

   OriginalPaper Pages: 17 - 26

3. Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers

   • Christopher Guerin
   • Alessandro Olivi
   • Henry Brem

   OriginalPaper Pages: 27 - 37

4. Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients

   • C. Kloft
   • E-U. Graefe
   • M. O. Karlsson

   OriginalPaper Pages: 39 - 52

5. A Phase II Study of Intravenous Exatecan Mesylate (DX-8951f) Administered Daily for Five Days Every Three Weeks to Patients with Metastatic Adenocarcinoma of the Colon or Rectum

   • Melanie E. Royce
   • Eric K. Rowinsky
   • Leonard B. Saltz

   OriginalPaper Pages: 53 - 61

6. Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study

   • Anil Tulpule
   • Byron M. Espina
   • Alexandra M. Levine

   OriginalPaper Pages: 63 - 68

7. A Phase II Study of 9-Nitro-Camptothecin in Patients with Previously Treated Metastatic Breast Cancer

   • Kathy D. Miller
   • Sharon E. Soule
   • George W. Sledge Jr

   OriginalPaper Pages: 69 - 73

8. Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group

   • Keith Stuart
   • Donna E. Levy
   • Al Bowen Benson III

   OriginalPaper Pages: 75 - 81

9. Subcutaneously Administered Recombinant Human Interleukin-2 and Interferon Alfa-2a for Advanced Breast Cancer: A Phase II study of the Cancer and Leukemia Group B (CALGB 9041)

   • Gretchen Kimmick
   • Mark J. Ratain
   • Hyman B. Muss

   OriginalPaper Pages: 83 - 89

10. Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study

    • Susan G. Urba
    • Kari Chansky
    • James L. Abbruzzese

    OriginalPaper Pages: 91 - 97